Our Focus
Clinical And Population Studies
Multi-Modal Research
Close Partnerships
Illuminating The Microbiome’s Impact On Health, Especially In Asians
• Understanding diet-microbiome interactions in Asian populations, including through
cross-sectional studies and longitudinal trials.
cross-sectional studies and longitudinal trials.
• Identifying microbial drivers and biomarkers for digestive and metabolically-related
cancers, and testing microbiome-based therapies.
• Uncovering how environmental exposures affect the microbiome and systemic disease.cancers, and testing microbiome-based therapies.
Research into the diet-microbiome interactions in Asians can lead to diagnostic and therapeutic solutions for cancer and other chronic conditions.
Our Impact
Microbiome Insights To Drive Better Healthcare And Treatments
• We found that Roseburia intestinalis, a probiotic species, has the potential to
boost treatment against colorectal cancer.
boost treatment against colorectal cancer.
• We established that obesity-associated microbiota increases colon cancer risk,
and pinpointed Alistipes fingoldii as a factor in the disease process.
and pinpointed Alistipes fingoldii as a factor in the disease process.
• We built a clinical platform to deliver diagnostics and precision health at scale.
Our centre utilises anaerobic culturing of stool communities for diverse functional analyses of the interplay of gut microbiome and a host of diseases
